Early Stage Biotech VC, 5AM Ventures, Grabs $250 Million

Published: Dec 05, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Like its name suggests, 5AM Venture Management likes to place its bets early in the life of a company. Now it has reloaded with another $250 million to put to work in more early-stage biotech companies. Menlo Park, CA-based 5AM Ventures said this week it has closed on 5AM Ventures IV, its fourth fund since it got going in 2002. The venture firm now has $685 million of total cash under management, including its most recent $200 million fund that closed almost exactly three years ago in December 2009, during some of the darker days for early-stage biotech venture capital.

Help employers find you! Check out all the jobs and post your resume.

Back to news